Nascent Pharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 11, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	2	1	6	21	4	9
Market Cap Growth	-77.69%	-85.56%	-72.61%	430.37%	-57.01%	-69.99%
Enterprise Value	-	18	23	33	11	14
Last Close Price	0.01	0.03	1.30	7.50	9.75	58.05
PS Ratio	1.70	0.39	0.86	4.56	2.32	3.99
PB Ratio	-0.18	-0.83	2.13	3.74	2.68	1.38
EV/Sales Ratio	-	8.26	3.40	7.12	6.49	6.23
Debt / Equity Ratio	-0.92	-9.16	3.46	1.30	1.41	0.02
Net Debt / Equity Ratio	-0.92	-9.13	3.43	1.22	1.10	0.01
Net Debt / EBITDA Ratio	-1.33	-1.50	-0.73	-0.70	-0.24	-0.01
Net Debt / FCF Ratio	36.54	-6.93	-2.35	-0.85	-0.81	-0.02
Asset Turnover	0.14	0.17	0.42	0.45	0.31	0.42
Inventory Turnover	2.47	0.99	1.78	1.11	0.49	1.37
Quick Ratio	0.12	0.34	0.54	0.43	1.11	2.57
Current Ratio	0.14	0.48	0.70	0.70	1.27	6.70
Return on Equity (ROE)	-	-1148.32%	-358.87%	-343.02%	-218.54%	-116.40%
Return on Assets (ROA)	-62.52%	-36.43%	-55.28%	-62.95%	-84.68%	-67.52%
Return on Capital Employed (ROCE)	76.30%	747.20%	-451.80%	-146.40%	-446.90%	-87.80%
Earnings Yield	-755.82%	-1172.96%	-259.58%	-57.98%	-224.36%	-64.10%
FCF Yield	-	-158.94%	-68.66%	-38.14%	-50.47%	-38.22%
Buyback Yield / Dilution	-608.91%	-252.66%	-165.79%	-470.01%	-71.71%	-45.69%